7 employees
Interface Biosciences is a platform therapeutics company that specializes in using the microbiome to treat inflammatory diseases.
2020
Interface Biosciences raised undisclosed on February 28, 2021
Investors: One Planet Ops
Interface Biosciences raised undisclosed on May 5, 2020
Investors: Pear VC